Cameron A E, Arnold R W, Ghorisa M W, Jamieson V
Anaesthesia. 1981 Mar;36(3):318-22. doi: 10.1111/j.1365-2044.1981.tb10211.x.
Bupivacaine 0.5% plain solution was used to produce spinal analgesia on 63 occasions. In 33 patients a fixed dose of 4 ml injected at the L2/3 interspace at 0.5 ml/second produced an extent of analgesia which was directly related to patient age (p les than 0.005). The latency was 17.3 minutes (SD 8 . 4) and duration of action was 286 minutes (SD 62). A second group receiving only 1 ml of solution had a much shorter duration of action (mean 154 minutes, SD 30). In 90% of patients the analgesia obtained was fully sufficient for surgery to be performed and no form of analgesic supplementation was given. On two occasions no analgesia occurred at all. Bupivacaine 0.5% plain proved to be an effective agent for subarachnoid block. The extent of analgesia was, however, poorly predictable, and even with low doses unacceptably high level of block were sometimes achieved.
0.5%布比卡因原液用于产生脊髓镇痛63次。在33例患者中,以0.5毫升/秒的速度在L2/3椎间隙注入4毫升固定剂量,产生的镇痛程度与患者年龄直接相关(p小于0.005)。潜伏期为17.3分钟(标准差8.4),作用持续时间为286分钟(标准差62)。另一组仅接受1毫升溶液的患者作用持续时间短得多(平均154分钟,标准差30)。90%的患者获得的镇痛效果完全足以进行手术,未给予任何形式的镇痛补充。有两次根本没有出现镇痛效果。0.5%布比卡因原液被证明是一种有效的蛛网膜下腔阻滞药物。然而,镇痛程度难以预测,即使使用低剂量,有时也会出现高得难以接受的阻滞平面。